Fiche du document
- doi: 10.1038/ki.2013.377
- issn: 0085-2538
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1038/ki.2013.377
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/24172683
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1523-1755
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_D033D6592E295
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Treatments for diseases Medical treatment Therapy Treatment of diseases Disease (Pathology)Citer ce document
M. C. Pickering et al., « C3 glomerulopathy: consensus report », Serveur académique Lausannois, ID : 10.1038/ki.2013.377
Métriques
Partage / Export
Résumé
C3 glomerulopathy is a recently introduced pathological entity whose original definition was glomerular pathology characterized by C3 accumulation with absent or scanty immunoglobulin deposition. In August 2012, an invited group of experts (comprising the authors of this document) in renal pathology, nephrology, complement biology, and complement therapeutics met to discuss C3 glomerulopathy in the first C3 Glomerulopathy Meeting. The objectives were to reach a consensus on: the definition of C3 glomerulopathy, appropriate complement investigations that should be performed in these patients, and how complement therapeutics should be explored in the condition. This meeting report represents the current consensus view of the group.